CureVac Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	1,049	736	853	1,096	5,645	12,013
Market Cap Growth	58.58%	-13.78%	-22.11%	-80.59%	-53.01%	-
Enterprise Value	602.29	293.05	492.77	641.93	4,863	10,746
Last Close Price	4.66	3.41	4.21	6.03	34.31	81.07
PE Ratio	4.98	4.10	-	-	-	-
PS Ratio	9.02	1.37	15.87	16.25	54.82	245.82
PB Ratio	0.82	1.06	1.71	2.05	8.20	16.89
P/TBV Ratio	-	1.10	1.86	2.14	9.27	15.07
P/FCF Ratio	-	8.41	-	-	-	24.71
P/OCF Ratio	-	7.22	-	-	-	23.00
EV/Sales Ratio	7.26	0.55	9.17	9.52	47.22	219.88
EV/EBITDA Ratio	2.65	1.37	-	-	-	-
EV/EBIT Ratio	2.82	1.51	-	-	-	-
EV/FCF Ratio	-	3.35	-	-	-	22.11
Debt / Equity Ratio	0.04	0.06	0.08	0.08	0.04	0.08
Debt / EBITDA Ratio	0.21	0.18	-	-	-	-
Debt / FCF Ratio	-	0.45	-	-	-	0.11
Asset Turnover	0.07	0.67	0.07	0.07	0.08	0.06
Inventory Turnover	22.28	-7.01	-5.79	-4.59	-6.74	-1.37
Quick Ratio	1.84	6.89	2.06	3.23	2.32	5.35
Current Ratio	3.70	7.28	2.35	3.74	2.63	5.61
Return on Equity (ROE)	18.60%	29.95%	-53.65%	-40.77%	-58.82%	-38.63%
Return on Assets (ROA)	20.02%	27.85%	-35.30%	-24.73%	-30.94%	-13.45%
Return on Invested Capital (ROIC)	38.19%	69.07%	-92.53%	-97.82%	-213.93%	-84.77%
Return on Capital Employed (ROCE)	20.45%	29.60%	-45.18%	-33.16%	-39.94%	-16.08%
Earnings Yield	14.40%	24.39%	-	-	-	-
FCF Yield	-	11.90%	-	-	-	4.05%
Buyback Yield / Dilution	38.70%	-1.97%	-16.84%	-1.65%	-40.71%	-36.72%
Total Shareholder Return	38.70%	-1.97%	-16.84%	-1.65%	-40.71%	-36.72%

SEC Filings: 10-K · 10-Q